Other
The Third People's Hospital of Kunshan
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 3 trials
Late-Stage Pipeline
100%
3 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Phase 3
3(100.0%)
3Total
Phase 3(3)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT04287660Phase 3Unknown
Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients
Role: collaborator
NCT04087967Phase 3Unknown
Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients
Role: collaborator
NCT04083911Phase 3Unknown
Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60
Role: collaborator
All 3 trials loaded